These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17485856)

  • 41. Construction of novel chimeric proteins through the truncation of SEC2 and Sak from Staphylococcus aureus.
    Hui J; Yu XJ; Cui XJ; Mu T; Lin JS; Ni P; Li H; You S; Hu FQ
    Biosci Biotechnol Biochem; 2014; 78(9):1514-21. PubMed ID: 25209498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and characterization of the bacterial plasminogen activator staphylokinase secreted by a recombinant Bacillus subtilis.
    Gerlach D; Kraft R; Behnke D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):314-22. PubMed ID: 3146168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Staphylokinase and its mutants: a new generation of thrombolytic agents].
    Lebrazi J; Elalamy I; Helft G; Samama MM
    J Mal Vasc; 1998 Apr; 23(2):92-8. PubMed ID: 9608920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosis.
    Collen D; Lijnen HR; Vanderschueren S
    Verh K Acad Geneeskd Belg; 1995; 57(3):183-96; discussion 196-8. PubMed ID: 7483814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New derivative of staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats.
    Szemraj J; Zakrzeska A; Brown G; Stankiewicz A; Gromotowicz A; Grędziński T; Chabielska E
    Pharmacol Rep; 2011; 63(5):1169-79. PubMed ID: 22180359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits.
    Li CJ; Huang J; Yang ZJ; Cao KJ
    Acta Pharmacol Sin; 2007 Jan; 28(1):58-65. PubMed ID: 17184583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integration of VEK-30 peptide enhances fibrinolytic properties of staphylokinase.
    Bhando T; Singh S; Hade MD; Kaur J; Dikshit KL
    Biotechnol Appl Biochem; 2021 Apr; 68(2):213-220. PubMed ID: 32233032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staphylokinase Enzyme: An Overview of Structure, Function and Engineered Forms.
    Vakili B; Nezafat N; Negahdaripour M; Yari M; Zare B; Ghasemi Y
    Curr Pharm Biotechnol; 2017; 18(13):1026-1037. PubMed ID: 29424308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris.
    Apte-Deshpnade A; Mandal G; Soorapaneni S; Prasad B; Kumar J; Padmanabhan S
    Biotechnol Lett; 2009 Jun; 31(6):811-7. PubMed ID: 19214390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Staphylokinase for a better thrombolytic treatment of heart and platelet diseases].
    Vanderschueren S
    Verh K Acad Geneeskd Belg; 2000; 62(1):69-75. PubMed ID: 10769618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of endothelial cells on activity of staphylokinase.
    Ueshima S; Okada K; Matsumoto H; Takaishi T; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):522-9. PubMed ID: 8874862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular and functional characterization of a Schistosoma bovis annexin: fibrinolytic and anticoagulant activity.
    de la Torre-Escudero E; Manzano-Román R; Siles-Lucas M; Pérez-Sánchez R; Moyano JC; Barrera I; Oleaga A
    Vet Parasitol; 2012 Feb; 184(1):25-36. PubMed ID: 21889851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Large-scale preparation of the delta10 form of staphylokinase by in vitro processing of recombinant staphylokinase with purified human plasminogen.
    Chattopadhyay D; Stewart JE; DeLucas LJ
    Appl Biochem Biotechnol; 1998 Mar; 69(3):147-56. PubMed ID: 9554081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cloning & expression of SAK enzyme from
    Muttar A; Numan IT
    J Med Life; 2022 Jun; 15(6):768-771. PubMed ID: 35928367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A fusion protein with improved thrombolytic effect and low bleeding risk.
    Wang X; Zhang G; Wang L; Zhang Q; Qin Y; Wu C; Yu A
    Thromb Haemost; 2009 Dec; 102(6):1194-203. PubMed ID: 19967151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The long amino-terminal tail domain of annexin XI is necessary for its nuclear localization.
    Mizutani A; Watanabe N; Kitao T; Tokumitsu H; Hidaka H
    Arch Biochem Biophys; 1995 Apr; 318(1):157-65. PubMed ID: 7726557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NMR secondary structure of the plasminogen activator protein staphylokinase.
    Ohlenschläger O; Ramachandran R; Flemming J; Gührs KH; Schlott B; Brown LR
    J Biomol NMR; 1997 Apr; 9(3):273-86. PubMed ID: 9204556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical characterization of annexin B1 from Cysticercus cellulosae.
    Winter A; Yusof AM; Gao E; Yan HL; Sun SH; Hofmann A
    FEBS J; 2006 Jul; 273(14):3238-47. PubMed ID: 16857011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction of novel bifunctional chimeric proteins possessing antitumor and thrombolytic activities.
    Hui J; Dai Y; Bian Y; Li H; Cui X; Yu X; You S; Hu F
    J Microbiol Biotechnol; 2012 Jul; 22(7):894-901. PubMed ID: 22580307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous removal of T and B cell epitope in recombinant staphylokinase by structure-based mutagenesis of immuno-dominant Arg77 and Glu80 residues.
    Xu R; He J; Jia K; Chen X; Liu J; Zhu K
    Wei Sheng Wu Xue Bao; 2011 May; 51(5):692-703. PubMed ID: 21800633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.